TOC  | ID |  STD 

Chancroid                                DX  |  RX  

Sexually Transmitted Diseases Treatment Guidelines 2002  MMWR May 10, 2002/Vol. 51/No.RR-6
http://wonder.cdc.gov/wonder/STD/STD98TG/STD98T09.HTM#STD98095
http://www.cdc.gov/nchstp/dstd/STD98TG.HTM

DX of chancroid
requires identification of H. ducreyi on special culture media that are not widely available from commercial sources; even using these media, sensitivity is less than or equal to 80%.
A probable diagnosis, for both clinical and surveillance purposes, may be made if the following criteria are met:

RX of Chancroid

NOTE: Ciprofloxacin is contraindicated for pregnant and lactating women and for persons aged less than 18 years.
All four regimens are effective for treatment of chancroid in HIV-infected patients.
Azithromycin and ceftriaxone offer the advantage of single-dose therapy.

Top  |  HomePage

Follow-Up
Patients should be reexamined 3-7 days after initiation of therapy. If treatment is successful, ulcers improve symptomatically within 3 days and objectively within 7 days after therapy. If no clinical improvement is evident, the clinician must consider whether

Management of Sex Partners
Sex partners of patients who have chancroid should be examined and treated, regardless of whether symptoms of the disease are present, if they had sexual contact with the patient during the 10 days preceding onset of symptoms in the patient.

HIV-infected patients who have chancroid should be monitored closely. Such patients may require longer courses of therapy than those recommended for HIV-negative patients. Healing may be slower among HIV-infected patients, and treatment failures occur with any regimen.

Top  |  HomePage